Vancouver, B.C. and Boston, MA, September 26, 2019 – Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) today announced it recently met with...
Read More
Effect of blue-light cystoscopy on contemporary performance of urine cytology.
Freifeld Y, Lotan Y.
BJU Int. 2019 Aug;124(2):251-257. doi: 10.1111/bju.14574. Epub 2018 Oct 21.
PMID: 30281893 Clinical Trial.
https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fpubmed.ncbi.nlm.nih.gov%2f30281893%2f&c=E,1,4gBnj_ScTnVhwBTw8ZTLp7S7mC68k2Ma4z6o9uVSt3oJ29TSjrsvvscJ806oNWYD5Q-x6LPig5RzvNMUeugWqcO0WgmmGaUleVGPL3P5mF2xSG9luodBIjf3aL0,&typo=1
Blue light flexible cystoscopy with hexaminolevulinate in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on optimal use in the USA - update 2018.
Lotan Y, Bivalacqua TJ, Downs T, Huang W, Jones J, Kamat AM, Konety B, Malmström PU, McKiernan J, O'Donnell M, Patel S, Pohar K, Resnick M, Sankin A, Smith A, Steinberg G, Trabulsi E, Woods M, Daneshmand S.
Nat Rev Urol. 2019 Jun;16(6):377-386. doi: 10.1038/s41585-019-0184-4.
PMID: 31019310 Free PMC article. Review.
https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fpubmed.ncbi.nlm.nih.gov%2f31019310%2f&c=E,1,SiwfCe--twcu5pXZsctjLaMPG8nQqX82kEUrYOOUE1auaoEsBeKFWYz6eGREJCQrwprmuu7WsGOqtGDo5dsiXre3VU6hpa3iX551d5Ia2GM,&typo=1
Blue Light Cystoscopy: Indications and Outcomes.
Pohar KS.
Curr Urol Rep. 2020 Apr 4;21(5):19. doi: 10.1007/s11934-020-0966-5.
PMID: 32248340 Review.
https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fpubmed.ncbi.nlm.nih.gov%2f32248340%2f&c=E,1,ajK_ub6b759V3FWcq_DlZ0ZIofblOPldOaIwG1sz9awMphcRjdmSv_YwcmzyxYubp9J4Hy14OBpJrN3Gv2hKK-ehP7Nd9Xit7RpuW7syBt3qVB9flt0,&typo=1
The use of blue light flexible cystoscopy with hexaminolevulinate & the diagnosis of bladder cancer.
Clinton TN, Lotan Y.
Future Oncol. 2018 Nov;14(27):2805-2810. doi: 10.2217/fon-2018-0328. Epub 2018 Jun 21.
PMID: 29925279 Review.
https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fpubmed.ncbi.nlm.nih.gov%2f29925279%2f&c=E,1,whPk_v4XrIxILe80ufZnSni-pAKcei3RQJoFdTGjQgFsNsLZFQraNjCLoGd3p7-TTII0CbCh8BGxUyYsyKttofqyjGCc9Ve2ewBxd_DuOmQ_gshzKmE66G2M&typo=1
The Impact of Blue Light Cystoscopy on the Diagnosis and Treatment of Bladder Cancer.
Pietzak EJ.
Curr Urol Rep. 2017 May;18(5):39. doi: 10.1007/s11934-017-0685-8.
PMID: 28324275 Review.
https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fpubmed.ncbi.nlm.nih.gov%2f28324275%2f&c=E,1,W0c5Fn4GCN2H3rtQplYWLCbVTk_uFTkkU7e4rNbAfBumNzFWNXJ0DnWgNNx0cOuSrLmYDH0LzmRDP2Bce4DNriM4NCAGjKxSO3vKvL2m&typo=1
Blue Light Cystoscopy in Patients with Suspected Non-Muscle Invasive Bladder Carcinoma: A Review of Clinical Utility [Internet].
Tran K, Severn M.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Feb 15.
PMID: 28825777 Free Books & Documents. Review.
https://linkprotect.cudasvc.com/url?a=https%3a%2f%2fpubmed.ncbi.nlm.nih.gov%2f28825777%2f&c=E,1,OxXvuw2LyEwXw6BW3Hqpd6VZSWJHa4exUeq4sZEc0w9UEOnvq6DsUacIPSua_2p73L30sdhxjeaYbDSCe497JrY0-UDEsI4fSYsQIZ6iw3HKMcyiAroLUmHHrl4,&typo=1
Vancouver, B.C. and Boston, MA, December 8, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that it is partnering with Optel,...
Read More
Vancouver, B.C. and Boston, MA, June 9, 2016 – Imagin Medical (CSE: IME) (OTC PINK: IMEXF) (Frankfurt/Stuttgart Stock Exchanges: DPD2) (the “Company”) announced today that it has signed a Collaborative...
Read More
Vancouver, B.C. and Boston, MA, April 12, 2016 – Imagin Medical (CSE: IME) (the “Company”) announced today that Dr. Stavros Demos, the inventor of the i/Blue Imaging System, has accepted...
Read More